Galectin-1 and HIV-1 Infection

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Initial binding of human immunodeficiency virus-1 (HIV-1) to CD4(+) cells is a critical, yet inefficient, step in establishing infection.
• Host factors, including C-type lectins, are known to facilitate HIV-1 cell entry.
• Soluble beta-galactoside-binding lectins, such as galectin-1, have been implicated in enhancing virion binding and target cell infection.

Purpose of the Study:

• To investigate the role of the galectin family in HIV-1 pathogenesis.
• To explore galectin-1's specific mechanism in facilitating HIV-1 binding and infection.
• To describe methods for studying galectin involvement in HIV-1 disease progression.

Main Methods:

• Describing methods to investigate the galectin family's role in HIV-1 disease.
• Utilizing assays to assess galectin-1's influence on virion binding.
• Evaluating galectin-1's impact on target cell infection in a lactose-dependent manner.

Main Results:

• Galectin-1 facilitates HIV-1 virion binding to susceptible cells.
• Galectin-1 enhances HIV-1 infection of target cells.
• This facilitation is dependent on lactose, not mannose, indicating a specific binding interaction.

Conclusions:

• Galectin-1 is a significant host factor influencing HIV-1 pathogenesis.
• The galectin family plays a crucial role in HIV-1 infection dynamics.
• Understanding galectin involvement provides insights into potential therapeutic targets for HIV-1.